Neurophysiological Investigation of the Approach-avoidance Axis in OCD: Applications to Neuromodulation

Recruiting N/A Interventional Study
Obsessive Compulsive Disorder (OCD) Neuromodulation
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
22 – 64
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
10 (estimated)
Sponsor
Baylor College of Medicine · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
We will recruit 10 patients with OCD meeting established criteria for surgical evaluation. Following informed consent and baseline evaluations, each will be implanted with permanent DBS SenSight leads and the Medtronic Percept RC IPG, which has on-device neural recording capability and rechargeability. We will collect a broad array of neurobehavioral data across two environments with complementar…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Principal diagnosis of OCD per DSM-5; 2. Adult between ages 22 and 64; 3. At least a five-year history of treatment-refractory OCD that causes substantial subjective distress and impairment in functioning; 4. Minimum score of 28 on the Y-BOCS; 5. Failed an adequate trial of a…
Contacts

Nicole Provenza, PhD

713-798-5060

nprovenz@bcm.edu

CONTACT